2026, 3(1), 1-3, Oct. 24, 2026
Neurological disorders remain a leading cause of global disability and are associated with significant biological and clinical diversity, which reduces the efficacy of standardized treatment approaches. Developments in genomics, multi-omics, biomarkers, imaging, artificial intelligence, and digi…
2026, 3(1), 1-9, Jan. 20, 2026
Hypotension is a frequent complication of subarachnoid block (SAB) that frequently requires pharmacological treatment. The purpose of this study was to compare the relative efficacy of two pre-loaded colloid preparations, Hydroxyethyl Starch (HES 6%) and Haemaccel, in decreasing the frequency an…